Position in EW
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$31,150,895
-$128,718,973 QoQ
Shares Held
344,361
-82.8% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#135
of 1,315 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in EW Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $951,017,652 across 59 Medical Devices names. EW ranks #5 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
5,542,438 | $502,920,823 | |
| 2 | BSX |
Boston Scientific Corp
|
2,414,223 | $103,039,037 | |
| 3 | GKOS |
GLAUKOS Corp
|
314,804 | $43,997,006 | |
| 4 | DXCM |
Dexcom Inc
|
532,804 | $35,884,349 | |
| 5 | EW |
Edwards Lifesciences Corp
This page
|
344,361 | $31,150,895 | |
| 6 | PEN |
Penumbra Inc
|
90,520 | $28,581,689 | |
| 7 | SYK |
Stryker Corp
|
51,116 | $16,093,361 | |
| 8 | GMED |
Globus Medical Inc
|
188,541 | $14,896,623 |
All Filings in EW
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,150,895 | 344,361 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $159,869,868 | 1,996,377 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $505,159,701 | 5,925,627 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $277,366,626 | 3,566,499 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $539,303,232 | 6,895,579 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $219,663,033 | 3,030,671 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $430,367,407 | 5,813,419 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $246,391,944 | 3,733,777 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $6,896,898 | 74,666 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $17,104,666 | 178,994 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $7,855,351 | 103,021 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $123,720,015 | 1,785,797 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $430,497,310 | 4,563,737 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $410,820,302 | 4,965,796 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $309,931,954 | 4,154,027 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $290,222,339 | 3,512,312 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $124,843,850 | 1,312,902 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $50,563,329 | 429,522 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $23,411,757 | 180,716 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $1,099,382 | 9,711 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,860,085 | 27,615 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $7,989,292 | 95,520 | Shares | Sole | 2021-05-17 | |
| 2020-09-30 | $3,044,733 | 38,145 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,733,991 | 39,560 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,611,631 | 13,846 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||